New CEO Appointment Alimentiv Inc appointed Pierre Gaudreault as the new Chief Executive Officer. This leadership change presents an opportunity to connect with the company during this transition period and potentially introduce new solutions that align with the CEO's vision.
Launch of Alimentiv Statistics The recent launch of Alimentiv Statistics signifies a strategic focus on statistical advisory and analysis services in clinical research. This could be an ideal time to engage with Alimentiv to offer complementary services or technologies to enhance their statistical capabilities.
Partnerships & Mergers Alimentiv Inc has partnered with companies like Summit Clinical Research and Virgo Surgical Video Solutions, indicating a proactive approach to collaboration. Leveraging these partnerships can open avenues for joint sales initiatives or packaged solutions to address a broader market.
Technology Integration with Veeva Systems The integration of Alimentiv's eTMF solution with Veeva Systems demonstrates a commitment to leveraging technology for operational efficiency. This alignment with digital solutions presents an opportunity to propose synergistic products or services that complement their technological advancements.
Competitive Landscape Alimentiv is positioned among leading players in the pharmaceutical research industry such as Medpace, IQVIA, and ICON plc. Understanding this competitive landscape can aid in tailoring sales strategies that highlight Alimentiv's unique value proposition and differentiate offerings in the market.
5.7K
$1B
75K$1B
10K$1B
1.7K$100M$1B
34K$1B
501$100M$1B
201$10M$50M
15K$1B
23K$1BAlimentiv uses 8 technology products and services including theTradeDesk, GitHub, jQuery Migrate, and more. Explore Alimentiv's tech stack below.
| Alimentiv Email Formats | Percentage |
| First.Last@alimentiv.com | 96% |
| First.MiddleLast@alimentiv.com | 2% |
| Last@alimentiv.com | 1% |
| First.Middle@alimentiv.com | 1% |
Pharmaceutical ManufacturingOntario, Canada501-1000 Employees
From 1986 to 2020 we operated as Robarts Clinical Trials and built a strong foundation in the medical research community. In 2020, we became Alimentiv but retained our commitment to clinical trials, medical imaging, and precision medicine for GI-related ailments.
Company Overview
Media & News
Funding & FinancialsAlimentiv's revenue is in the range of $10M$50M
Funding & FinancialsAlimentiv's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com